The entry of cloud technology in the software world has fundamentally changed how software is built, deployed, and scaled. Traditionally, applications were released only once or twice a year. Today, ...

Cloud is for everyone, but not every single thing. This much we know. Generative AI is certainly also for everyone, but ...

Research indicates low-dose lithium may help slow deterioration in verbal memory among older adults with mild cognitive impairment. The effect appeared stronger in those with amyloid beta, a biomarker ...

Dyne has aligned with the U.S. Food and Drug Administration (FDA) on the HARMONIA Phase 3 trial design and protocol. HARMONIA is intended to serve as a confirmatory trial to support conversion of ...

Dyne Therapeutics maintains a strong $1.1B cash position, funding operations into mid-2028 despite heavy R&D and operating ...

Discover the impact of digital pathology on drug discovery and biomarker research this International Women’s Day with Dr ...

Dyne Therapeutics has initiated the Phase III HARMONIA trial to evaluate the efficacy, safety, and tolerability of zeleciment basivarsen (z-basivarsen, also called DYNE-101) in individuals diagnosed ...

Wipro Enterprises is considering entering semiconductor manufacturing, likely chip assembly, taking a cue from other large ...

Modernise your design strategy with mobile-first and keyboard-centric approaches that create more resilient, accessible, and user-friendly software.

A randomized clinical trial involving 958 older adults suggests that taking a daily multivitamin for two years may produce a small, statistically significant slowdown in two measures of biological ...

In this report, IBRAHIM ADAM examines how gaps in medical testing and neglected laboratory tests put patients at serious risk, with unnecessary surgeries and mismanaged treatments claiming livesThe ...